4.6 Letter

Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts

Journal

HAEMATOLOGICA
Volume 101, Issue 5, Pages -

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2015.139717

Keywords

flow cytometry; complementary diagnostics; AML; idasanutlin; MDM2 antagonism

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available